Wells Fargo & Company Cuts Teladoc Health (NYSE:TDOC) Price Target to $15.00

Teladoc Health (NYSE:TDOC) had its target price decreased by Wells Fargo & Company from $17.00 to $15.00 in a research report report published on Monday, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the health services provider’s stock.

TDOC has been the topic of a number of other research reports. Oppenheimer dropped their target price on Teladoc Health from $26.00 to $21.00 and set an outperform rating on the stock in a research report on Friday, April 26th. Needham & Company LLC reissued a hold rating on shares of Teladoc Health in a research note on Friday, April 26th. Evercore ISI dropped their target price on Teladoc Health from $15.00 to $14.00 and set an in-line rating for the company in a report on Friday, April 26th. Barclays lowered their price target on Teladoc Health from $25.00 to $20.00 and set an overweight rating for the company in a report on Friday, April 26th. Finally, Truist Financial lowered their price target on Teladoc Health from $23.00 to $17.00 and set a hold rating for the company in a report on Wednesday, March 6th. Twelve equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Hold and an average target price of $18.73.

Teladoc Health Stock Up 0.4 %

NYSE:TDOC opened at $12.81 on Monday. The company has a current ratio of 3.82, a quick ratio of 3.47 and a debt-to-equity ratio of 0.67. The stock has a fifty day simple moving average of $14.54 and a 200-day simple moving average of $17.63. The company has a market cap of $2.17 billion, a price-to-earnings ratio of -8.95 and a beta of 0.94. Teladoc Health has a twelve month low of $12.53 and a twelve month high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.37) earnings per share. Analysts anticipate that Teladoc Health will post -1.06 EPS for the current year.

Insider Transactions at Teladoc Health

In related news, COO Michael Willem Waters sold 4,523 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $86,751.14. Following the transaction, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CTO Nikolaos P. Nanis sold 2,866 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $41,614.32. Following the sale, the chief technology officer now directly owns 69,850 shares in the company, valued at $1,014,222. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Michael Willem Waters sold 4,523 shares of Teladoc Health stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $86,751.14. Following the completion of the sale, the chief operating officer now owns 38,570 shares in the company, valued at $739,772.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 135,441 shares of company stock valued at $2,038,251. Corporate insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently bought and sold shares of TDOC. ICA Group Wealth Management LLC acquired a new position in shares of Teladoc Health in the fourth quarter worth $28,000. Hexagon Capital Partners LLC increased its position in shares of Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after acquiring an additional 1,065 shares during the last quarter. RIA Advisory Group LLC purchased a new stake in shares of Teladoc Health during the fourth quarter worth about $36,000. GAMMA Investing LLC bought a new stake in Teladoc Health in the fourth quarter valued at about $41,000. Finally, Principal Securities Inc. bought a new stake in Teladoc Health in the fourth quarter valued at about $45,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.